BELLUS Health’s product strategy targets both pharmaceuticals and nutraceuticals. The Company’s pharmaceuticals portfolio of products includes investigational product candidates for the treatment of Amyloid A amyloidosis and Alzheimer’s disease. With respect to nutraceuticals, the Company is commercializing, through distributors, a natural health product designed to protect memory function.